Aditya Tallapragada is the President of AKT Health, a global life sciences strategy and operations organization with a presence across India, Japan, the United States, and the UAE. With over a decade of leadership in the life sciences sector, Aditya has built AKT Health into a trusted partner for pharmaceutical, biotechnology, and medical device companies navigating complex multi-market regulatory and commercial environments.

Under his leadership, AKT Health has developed an integrated operational framework spanning Clinical & Regulatory Operations, Pharmacovigilance, Health Economics & Outcomes Research (HEOR), Market Access, and Medical Affairs with a particular focus on GCC market entry and compliance with regional authorities including SFDA and MOHAP. The organization’s proprietary digital platforms, Datakapt and Vigil, reflect Aditya’s commitment to embedding technology at the core of life sciences operations to drive faster, more evidence-based decision-making. Aditya’s strategic vision centers on translating global clinical and commercial intent into locally executable market strategies enabling clients to move from regulatory complexity to sustainable growth. His approach prioritizes capability transfer, ensuring that partner organizations build long-term internal competency rather than ongoing dependency. Recognized for his ability to bridge scientific rigor with commercial pragmatism, Aditya continues to shape AKT Health’s expansion as the GCC life sciences landscape evolves toward unified HTA frameworks and the 2030 cross-border dossier recognition goal.